No Data
No Data
No Data
No Data
No Data
Insufficient Growth At Twist Bioscience Corporation (NASDAQ:TWST) Hampers Share Price
You may think that with a price-to-sales (or "P/S") ratio of 6.2x Twist Bioscience Corporation (NASDAQ:TWST) is definitely a stock worth checking out, seeing as almost half of all the Biotechs compani
Simply Wall StApr 22 20:25
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Company to host conference call at 4:30 p.m. ET Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today
BusinesswireApr 18 20:00
Twist Bioscience Is Maintained at Overweight by Barclays
Twist Bioscience Is Maintained at Overweight by Barclays
Dow JonesApr 11 03:36
Twist Bioscience Price Target Cut to $40.00/Share From $45.00 by Barclays
Twist Bioscience Price Target Cut to $40.00/Share From $45.00 by Barclays
Dow JonesApr 11 03:36
Barclays: Maintain the Twist Bioscience (TWST.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $45.00 to $40.00.
Barclays: Maintain the Twist Bioscience (TWST.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $45.00 to $40.00.
Zhitong FinanceApr 11 03:30
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $40
Barclays analyst Luke Sergott maintains Twist Bioscience with a Overweight and lowers the price target from $45 to $40.
Analyst UpgradesApr 11 03:25
No Data
No Data